These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 205787)

  • 1. Renin inhibitors.
    Haber E
    N Engl J Med; 1978 May; 298(18):1023-5. PubMed ID: 205787
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
    Waeber B; Brunner HR; Wauters JP; Gavras H
    Adv Nephrol Necker Hosp; 1981; 10():111-33. PubMed ID: 6267906
    [No Abstract]   [Full Text] [Related]  

  • 3. [Renin-angiotensin system blocking drugs in the diagnosis and treatment of arterial hypertension].
    Kabat M; Makowiecka-Cieśla M
    Kardiol Pol; 1984; 27(2):147-57. PubMed ID: 6328092
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of specific angiotensin inhibitors in the diagnosis and treatment of arterial hypertension].
    Novikova LS; Arabidze GG
    Ter Arkh; 1979; 51(5):99-108. PubMed ID: 222004
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of saralasin to evaluate the function of the brain renin-angiotensin system.
    Reid IA
    Prog Biochem Pharmacol; 1976; 12():117-34. PubMed ID: 1019160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs].
    Lazowski J
    Wiad Lek; 1984 May; 37(10):792-6. PubMed ID: 6095537
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of inhibition of angiotensin I converting enzyme with SQ-14225 on the arterial blood pressure of mongrel dogs.
    Jandhyala BS; Washington GF; Lokhandwala MF
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):257-65. PubMed ID: 216064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.
    Johnston CI; Clappison B; McGrath BP; Matthews PG; Millar JA; Anderson WP
    Prog Biochem Pharmacol; 1980; 17():123-33. PubMed ID: 6259649
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of renin-angiotensin system inhibitors in the diagnosis of hypertension].
    Stumpe KO; Kolloch RE; Overlack A
    Med Welt; 1977 Oct; 28(41):1645-9. PubMed ID: 927124
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.
    McCaa RE
    Prog Biochem Pharmacol; 1980; 17():29-35. PubMed ID: 7010367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical pharacology of the new antihypertensive drugs: renin-angiotensin system antagonists, recent vasodilators and dopaminergic agonists].
    Andréjak M; Hardin JM; Makdassi R; Bataille P; Gheerbrant JD; Fournier A
    Rev Prat; 1979 Dec; 29(57):4385-93. PubMed ID: 232771
    [No Abstract]   [Full Text] [Related]  

  • 13. Renin inhibitors: novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering?
    Weir MR
    Curr Opin Nephrol Hypertens; 2007 Sep; 16(5):416-21. PubMed ID: 17693755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of renin or angiotensin for understanding human hypertension: a comparison of propranolol, saralasin and converting enzyme blockade.
    Laragh JH; Case DB; Wallace JM; Keim H
    Fed Proc; 1977 Apr; 36(5):1781-7. PubMed ID: 191300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA; Derkx FH; van den Meiracker AH
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saralasin testing for renin-dependent hypertension.
    Weber MA
    Arch Intern Med; 1979 Jan; 139(1):93-5. PubMed ID: 760691
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of converting-enzyme inhibitors on the renin-angiotensin-aldosterone, bradykinin, and arachidonic acid-prostaglandin systems: correlation of chemical structure and biologic activity.
    Zusman RM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):13-23. PubMed ID: 3037886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal responses to angiotensin blockade. Comparison between receptor antagonism and converting enzyme inhibition.
    Johnston CI; Millar JA; Casley DJ; McGrath BP; Matthews PG
    Circ Res; 1980 Jun; 46(6 Pt 2):I128-34. PubMed ID: 6247084
    [No Abstract]   [Full Text] [Related]  

  • 20. Accentuated vascular and endocrine response to SQ 20881 in hypertension.
    Williams GH; Hollenberg NK
    N Engl J Med; 1977 Jul; 297(4):184-8. PubMed ID: 195203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.